More specifically increases in inflammatory mediators such as TNF-alpha, IL1-beta, ICAM-1, and IL-6, and markers of vascular injury such as VCAM-1, VEGF, and von Willebrand factor have been identified in patients with SSc-PAH [7]. Here, TNF is linked to systemic sclerosis.